Quote from squeeze:
I wasn't convinced by the paper which was very short on real detail and seemed to involve over-fitting.
...
Even if it did work on a broader base of HF returns, it is still a technique for reproducing averageness and I don't see much value in this.
Well, the lack of detail in that paper is by design -- it's a self-described intro, focusing on examples and results... not much more than an executive summary, you could say. I don't agree on the over-fitting part at all. Look for the other papers by Kat and Palaro at the same SSRN website for a lot more detail.
I can easily see certain institutional investors buying into this idea of synthetic HF returns replication, with enthusiasm. Obviously, Goldman must see large potential bottom-line value there, to go ahead with the launch of that ART fund.